These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 24412751)
21. Structure and function of Norrin in assembly and activation of a Frizzled 4-Lrp5/6 complex. Ke J; Harikumar KG; Erice C; Chen C; Gu X; Wang L; Parker N; Cheng Z; Xu W; Williams BO; Melcher K; Miller LJ; Xu HE Genes Dev; 2013 Nov; 27(21):2305-19. PubMed ID: 24186977 [TBL] [Abstract][Full Text] [Related]
22. Activation/Proliferation-associated Protein 2 (Caprin-2) Positively Regulates CDK14/Cyclin Y-mediated Lipoprotein Receptor-related Protein 5 and 6 (LRP5/6) Constitutive Phosphorylation. Wang X; Jia Y; Fei C; Song X; Li L J Biol Chem; 2016 Dec; 291(51):26427-26434. PubMed ID: 27821587 [TBL] [Abstract][Full Text] [Related]
23. Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-catenin. Yamamoto H; Komekado H; Kikuchi A Dev Cell; 2006 Aug; 11(2):213-23. PubMed ID: 16890161 [TBL] [Abstract][Full Text] [Related]
24. Structure of the Wnt-Frizzled-LRP6 initiation complex reveals the basis for coreceptor discrimination. Tsutsumi N; Hwang S; Waghray D; Hansen S; Jude KM; Wang N; Miao Y; Glassman CR; Caveney NA; Janda CY; Hannoush RN; Garcia KC Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2218238120. PubMed ID: 36893265 [TBL] [Abstract][Full Text] [Related]
25. Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling. Janda CY; Dang LT; You C; Chang J; de Lau W; Zhong ZA; Yan KS; Marecic O; Siepe D; Li X; Moody JD; Williams BO; Clevers H; Piehler J; Baker D; Kuo CJ; Garcia KC Nature; 2017 May; 545(7653):234-237. PubMed ID: 28467818 [TBL] [Abstract][Full Text] [Related]
26. Analysis of endogenous LRP6 function reveals a novel feedback mechanism by which Wnt negatively regulates its receptor. Khan Z; Vijayakumar S; de la Torre TV; Rotolo S; Bafico A Mol Cell Biol; 2007 Oct; 27(20):7291-301. PubMed ID: 17698587 [TBL] [Abstract][Full Text] [Related]
27. Aberrantly activated Wnt/β-catenin pathway co-receptors LRP5 and LRP6 regulate osteoblast differentiation in the developing coronal sutures of an Apert syndrome (Fgfr2 Min Swe NM; Kobayashi Y; Kamimoto H; Moriyama K Dev Dyn; 2021 Mar; 250(3):465-476. PubMed ID: 32822074 [TBL] [Abstract][Full Text] [Related]
28. p38 MAP kinase is required for Wnt3a-mediated osterix expression independently of Wnt-LRP5/6-GSK3β signaling axis in dental follicle cells. Sakisaka Y; Kanaya S; Nakamura T; Tamura M; Shimauchi H; Nemoto E Biochem Biophys Res Commun; 2016 Sep; 478(2):527-32. PubMed ID: 27450807 [TBL] [Abstract][Full Text] [Related]
30. Regulated proteolytic processing of LRP6 results in release of its intracellular domain. Mi K; Johnson GV J Neurochem; 2007 Apr; 101(2):517-29. PubMed ID: 17326769 [TBL] [Abstract][Full Text] [Related]
31. The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo. Bryja V; Andersson ER; Schambony A; Esner M; Bryjová L; Biris KK; Hall AC; Kraft B; Cajanek L; Yamaguchi TP; Buckingham M; Arenas E Mol Biol Cell; 2009 Feb; 20(3):924-36. PubMed ID: 19056682 [TBL] [Abstract][Full Text] [Related]
32. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Semënov MV; Tamai K; Brott BK; Kühl M; Sokol S; He X Curr Biol; 2001 Jun; 11(12):951-61. PubMed ID: 11448771 [TBL] [Abstract][Full Text] [Related]
33. Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells. Fenderico N; van Scherpenzeel RC; Goldflam M; Proverbio D; Jordens I; Kralj T; Stryeck S; Bass TZ; Hermans G; Ullman C; Aastrup T; Gros P; Maurice MM Nat Commun; 2019 Jan; 10(1):365. PubMed ID: 30664649 [TBL] [Abstract][Full Text] [Related]
34. Frizzled receptors facilitate Tiki inhibition of Wnt signaling at the cell surface. Li M; Zheng J; Luo D; Xu K; Sheng R; MacDonald BT; He X; Zhang X EMBO Rep; 2023 Jun; 24(6):e55873. PubMed ID: 36994853 [TBL] [Abstract][Full Text] [Related]
35. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity. Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037 [TBL] [Abstract][Full Text] [Related]